Skip to main content
Erschienen in: Journal of Neuro-Oncology 1/2012

01.05.2012 | Clinical Study

Significance of target location relative to the depth from the brain surface and high-dose irradiated volume in the development of brain radionecrosis after micromultileaf collimator-based stereotactic radiosurgery for brain metastases

verfasst von: Kazuhiro Ohtakara, Shinya Hayashi, Noriyuki Nakayama, Naoyuki Ohe, Hirohito Yano, Toru Iwama, Hiroaki Hoshi

Erschienen in: Journal of Neuro-Oncology | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

The objective of this study was to investigate the factors that potentially lead to brain radionecrosis (RN) after micromultileaf collimator-based stereotactic radiosurgery (SRS) for brain metastases. We retrospectively evaluated 131 lesions with a minimum follow-up of 6 months, 43.5% of which received prior whole-brain radiotherapy (WBRT). The three-tiered location grade (LG) was defined, as follows, for each target by considering mainly the depth from the brain surface: grade 1 (superficial), involving the region at a depth of ≤5 mm from the brain surface; grade 2 (deep), located at a depth of >5 mm from the brain surface; and grade 3 (central), located in the brainstem, cerebellar peduncle, diencephalon, or basal ganglion. The predictive factors for RN, including high-dose irradiated isodose volumes (IIDVs) and LG, were evaluated by univariate and multivariate analysis. Symptomatic RN (S-RN) and asymptomatic RN (A-RN) were observed in 8.4% and 6.9% of cases, respectively. Multivariate analysis indicated that the significant factors for both types of RN were LG, V12 Gy, and V22 Gy in all cases; V22 Gy and LG for the non-WBRT cases; and V15 Gy and LG for the WBRT cases. For the non-WBRT cases, the cutoff values of V22 Gy were 2.62 and 2.14 cm3 for S-RN and both RN, respectively. For the WBRT cases, the cutoff values of V15 Gy were 5.61 and 5.20 cm3 for S-RN and both RN, respectively. In addition to the IIDV data, LG helps predict the risk of RN. High-dose IIDV, V22 Gy, was also significantly correlated with RN, particularly for patients treated with SRS alone.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Linskey ME, Andrews DW, Asher AL et al (2010) The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96:45–68PubMedCrossRef Linskey ME, Andrews DW, Asher AL et al (2010) The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96:45–68PubMedCrossRef
2.
Zurück zum Zitat Wiggenraad R, Verbeek-de Kanter A, Kal HB, Taphoorn M, Vissers T, Struikmans H (2011) Dose-effect relation in stereotactic radiotherapy for brain metastases. A systematic review. Radiother Oncol 98:292–297 Wiggenraad R, Verbeek-de Kanter A, Kal HB, Taphoorn M, Vissers T, Struikmans H (2011) Dose-effect relation in stereotactic radiotherapy for brain metastases. A systematic review. Radiother Oncol 98:292–297
3.
Zurück zum Zitat Maranzano E, Trippa F, Casale M et al. (2012) Reirradiation of brain metastases with radiosurgery. Radiother Oncol 102:192–197 Maranzano E, Trippa F, Casale M et al. (2012) Reirradiation of brain metastases with radiosurgery. Radiother Oncol 102:192–197
4.
Zurück zum Zitat Maldaun MV, Aguiar PH, Lang F, Suki D, Wildrick D, Sawaya R (2008) Radiosurgery in the treatment of brain metastases: critical review regarding complications. Neurosurg Rev 31:1–9PubMedCrossRef Maldaun MV, Aguiar PH, Lang F, Suki D, Wildrick D, Sawaya R (2008) Radiosurgery in the treatment of brain metastases: critical review regarding complications. Neurosurg Rev 31:1–9PubMedCrossRef
5.
Zurück zum Zitat Williams BJ, Suki D, Fox BD et al (2009) Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complications. J Neurosurg 111:439–448PubMedCrossRef Williams BJ, Suki D, Fox BD et al (2009) Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complications. J Neurosurg 111:439–448PubMedCrossRef
6.
Zurück zum Zitat Minniti G, Clarke E, Lanzetta G et al (2011) Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol 6:48PubMedCrossRef Minniti G, Clarke E, Lanzetta G et al (2011) Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol 6:48PubMedCrossRef
7.
Zurück zum Zitat Voges J, Treuer H, Sturm V et al (1996) Risk analysis of linear accelerator radiosurgery. Int J Radiat Oncol Biol Phys 36:1055–1063PubMedCrossRef Voges J, Treuer H, Sturm V et al (1996) Risk analysis of linear accelerator radiosurgery. Int J Radiat Oncol Biol Phys 36:1055–1063PubMedCrossRef
8.
Zurück zum Zitat Karlsson B, Lax I, Söderman M (1997) Factors influencing the risk for complications following Gamma Knife radiosurgery of cerebral arteriovenous malformations. Radiother Oncol 43:275–280PubMedCrossRef Karlsson B, Lax I, Söderman M (1997) Factors influencing the risk for complications following Gamma Knife radiosurgery of cerebral arteriovenous malformations. Radiother Oncol 43:275–280PubMedCrossRef
9.
Zurück zum Zitat Chin LS, Ma L, DiBiase S (2001) Radiation necrosis following gamma knife surgery: a case-controlled comparison of treatment parameters and long-term clinical follow up. J Neurosurg 94:899–904PubMedCrossRef Chin LS, Ma L, DiBiase S (2001) Radiation necrosis following gamma knife surgery: a case-controlled comparison of treatment parameters and long-term clinical follow up. J Neurosurg 94:899–904PubMedCrossRef
10.
Zurück zum Zitat Valéry CA, Cornu P, Noël G et al (2003) Predictive factors of radiation necrosis after radiosurgery for cerebral metastases. Stereotact Funct Neurosurg 81:115–119PubMedCrossRef Valéry CA, Cornu P, Noël G et al (2003) Predictive factors of radiation necrosis after radiosurgery for cerebral metastases. Stereotact Funct Neurosurg 81:115–119PubMedCrossRef
11.
Zurück zum Zitat Korytko T, Radivoyevitch T, Colussi V et al (2006) 12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors. Int J Radiat Oncol Biol Phys 64:419–424PubMedCrossRef Korytko T, Radivoyevitch T, Colussi V et al (2006) 12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors. Int J Radiat Oncol Biol Phys 64:419–424PubMedCrossRef
12.
Zurück zum Zitat Blonigen BJ, Steinmetz RD, Levin L, Lamba MA, Warnick RE, Breneman JC (2010) Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 77:996–1001PubMedCrossRef Blonigen BJ, Steinmetz RD, Levin L, Lamba MA, Warnick RE, Breneman JC (2010) Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 77:996–1001PubMedCrossRef
13.
Zurück zum Zitat Lawrence YR, Li XA, el Naqa I et al (2010) Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys 76(3 Suppl):S20–S27PubMedCrossRef Lawrence YR, Li XA, el Naqa I et al (2010) Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys 76(3 Suppl):S20–S27PubMedCrossRef
14.
Zurück zum Zitat Sawaya R, Hammoud M, Schoppa D et al (1998) Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 42:1044–1056PubMedCrossRef Sawaya R, Hammoud M, Schoppa D et al (1998) Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 42:1044–1056PubMedCrossRef
15.
Zurück zum Zitat Ohtakara K, Hayashi S, Hoshi H (2012) Characterisation of dose distribution in linear accelerator-based intracranial stereotactic radiosurgery with the dynamic conformal arc technique: Consideration of the optimal method for dose prescription and evaluation. Br J Radiol 85:69–76PubMedCrossRef Ohtakara K, Hayashi S, Hoshi H (2012) Characterisation of dose distribution in linear accelerator-based intracranial stereotactic radiosurgery with the dynamic conformal arc technique: Consideration of the optimal method for dose prescription and evaluation. Br J Radiol 85:69–76PubMedCrossRef
16.
Zurück zum Zitat Kang TW, Kim ST, Byun HS et al (2009) Morphological and functional MRI, MRS, perfusion and diffusion changes after radiosurgery of brain metastasis. Eur J Radiol 72:370–380PubMedCrossRef Kang TW, Kim ST, Byun HS et al (2009) Morphological and functional MRI, MRS, perfusion and diffusion changes after radiosurgery of brain metastasis. Eur J Radiol 72:370–380PubMedCrossRef
17.
Zurück zum Zitat Dequesada IM, Quisling RG, Yachnis A, Friedman WA (2008) Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? A radiographic-pathological study. Neurosurgery 63:898–904PubMedCrossRef Dequesada IM, Quisling RG, Yachnis A, Friedman WA (2008) Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? A radiographic-pathological study. Neurosurgery 63:898–904PubMedCrossRef
18.
Zurück zum Zitat Kano H, Kondziolka D, Lobato-Polo J, Zorro O, Flickinger JC, Lunsford LD (2010) T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery. Neurosurgery 66:486–492PubMedCrossRef Kano H, Kondziolka D, Lobato-Polo J, Zorro O, Flickinger JC, Lunsford LD (2010) T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery. Neurosurgery 66:486–492PubMedCrossRef
19.
Zurück zum Zitat Jain R, Narang J, Sundgren PM et al (2010) Treatment induced necrosis versus recurrent/progressing brain tumor: going beyond the boundaries of conventional morphologic imaging. J Neurooncol 100:17–29PubMedCrossRef Jain R, Narang J, Sundgren PM et al (2010) Treatment induced necrosis versus recurrent/progressing brain tumor: going beyond the boundaries of conventional morphologic imaging. J Neurooncol 100:17–29PubMedCrossRef
20.
Zurück zum Zitat Patel TR, McHugh BJ, Bi WL et al. (2011) A Comprehensive Review of MR Imaging Changes Following Radiosurgery to 500 Brain Metastases. AJNR Am J Neuroradiol 32:1885–1892 Patel TR, McHugh BJ, Bi WL et al. (2011) A Comprehensive Review of MR Imaging Changes Following Radiosurgery to 500 Brain Metastases. AJNR Am J Neuroradiol 32:1885–1892
21.
Zurück zum Zitat Asao C, Korogi Y, Kitajima M et al (2005) Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence. AJNR Am J Neuroradiol 26:1455–1460PubMed Asao C, Korogi Y, Kitajima M et al (2005) Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence. AJNR Am J Neuroradiol 26:1455–1460PubMed
22.
Zurück zum Zitat Shaw E, Scott C, Souhami L et al (2000) Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90–05. Int J Radiat Oncol Biol Phys 47:291–298PubMedCrossRef Shaw E, Scott C, Souhami L et al (2000) Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90–05. Int J Radiat Oncol Biol Phys 47:291–298PubMedCrossRef
23.
Zurück zum Zitat Kjellberg RN, Hanamura T, Davis KR, Lyons SL, Adams RD (1983) Bragg-peak proton-beam therapy for arteriovenous malformations of the brain. N Engl J Med 309:269–274PubMedCrossRef Kjellberg RN, Hanamura T, Davis KR, Lyons SL, Adams RD (1983) Bragg-peak proton-beam therapy for arteriovenous malformations of the brain. N Engl J Med 309:269–274PubMedCrossRef
24.
Zurück zum Zitat Flickinger JC (1989) An integrated logistic formula for prediction of complications from radiosurgery. Int J Radiat Oncol Biol Phys 17:879–885PubMedCrossRef Flickinger JC (1989) An integrated logistic formula for prediction of complications from radiosurgery. Int J Radiat Oncol Biol Phys 17:879–885PubMedCrossRef
25.
Zurück zum Zitat Flickinger JC, Schell MC, Larson DA (1990) Estimation of complications for linear accelerator radiosurgery with the integrated logistic formula. Int J Radiat Oncol Biol Phys 19:143–148PubMedCrossRef Flickinger JC, Schell MC, Larson DA (1990) Estimation of complications for linear accelerator radiosurgery with the integrated logistic formula. Int J Radiat Oncol Biol Phys 19:143–148PubMedCrossRef
26.
Zurück zum Zitat Ohtakara K, Hayashi S, Hoshi H (2011) The relation between various conformity indices and the influence of the target coverage difference in prescription isodose surface on these values in intracranial stereotactic radiosurgery. Br J Radiol (in press) doi:10.1259/bjr/36606138 Ohtakara K, Hayashi S, Hoshi H (2011) The relation between various conformity indices and the influence of the target coverage difference in prescription isodose surface on these values in intracranial stereotactic radiosurgery. Br J Radiol (in press) doi:10.​1259/​bjr/​36606138
27.
Zurück zum Zitat Ma L, Petti P, Wang B et al (2011) Apparatus dependence of normal brain tissue dose in stereotactic radiosurgery for multiple brain metastases. J Neurosurg 114:1580–1584PubMedCrossRef Ma L, Petti P, Wang B et al (2011) Apparatus dependence of normal brain tissue dose in stereotactic radiosurgery for multiple brain metastases. J Neurosurg 114:1580–1584PubMedCrossRef
28.
Zurück zum Zitat Ohtakara K, Hayashi S, Tanaka H, Hoshi H (2011) Consideration of optimal isodose surface (IDS) selection for target coverage in micro-multileaf collimator-based stereotactic radiotherapy for large cystic brain metastases: Comparison of 90, 80, and 70% IDS-based planning. Br J Radiol (in press) Ohtakara K, Hayashi S, Tanaka H, Hoshi H (2011) Consideration of optimal isodose surface (IDS) selection for target coverage in micro-multileaf collimator-based stereotactic radiotherapy for large cystic brain metastases: Comparison of 90, 80, and 70% IDS-based planning. Br J Radiol (in press)
29.
Zurück zum Zitat Nataf F, Schlienger M, Liu Z et al (2008) Radiosurgery with or without a 2-mm margin for 93 single brain metastases. Int J Radiat Oncol Biol Phys 70:766–772PubMedCrossRef Nataf F, Schlienger M, Liu Z et al (2008) Radiosurgery with or without a 2-mm margin for 93 single brain metastases. Int J Radiat Oncol Biol Phys 70:766–772PubMedCrossRef
30.
Zurück zum Zitat Ma J, Chang Z, Wang Z, Jackie WuQ, Kirkpatrick JP, Yin FF (2009) ExacTrac X-ray 6 degree-of-freedom image-guidance for intracranial non-invasive stereotactic radiotherapy: comparison with kilo-voltage cone-beam CT. Radiother Oncol 93:602–608PubMedCrossRef Ma J, Chang Z, Wang Z, Jackie WuQ, Kirkpatrick JP, Yin FF (2009) ExacTrac X-ray 6 degree-of-freedom image-guidance for intracranial non-invasive stereotactic radiotherapy: comparison with kilo-voltage cone-beam CT. Radiother Oncol 93:602–608PubMedCrossRef
31.
Zurück zum Zitat Gaspar L, Scott C, Rotman M et al (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745–751PubMedCrossRef Gaspar L, Scott C, Rotman M et al (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745–751PubMedCrossRef
32.
Zurück zum Zitat Ernst-Stecken A, Ganslandt O, Lambrecht U, Sauer R, Grabenbauer G (2006) Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity. Radiother Oncol 81:18–24PubMedCrossRef Ernst-Stecken A, Ganslandt O, Lambrecht U, Sauer R, Grabenbauer G (2006) Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity. Radiother Oncol 81:18–24PubMedCrossRef
Metadaten
Titel
Significance of target location relative to the depth from the brain surface and high-dose irradiated volume in the development of brain radionecrosis after micromultileaf collimator-based stereotactic radiosurgery for brain metastases
verfasst von
Kazuhiro Ohtakara
Shinya Hayashi
Noriyuki Nakayama
Naoyuki Ohe
Hirohito Yano
Toru Iwama
Hiroaki Hoshi
Publikationsdatum
01.05.2012
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 1/2012
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-012-0834-3

Weitere Artikel der Ausgabe 1/2012

Journal of Neuro-Oncology 1/2012 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.